Changes in body mass index among people living with HIV who are new on highly active antiretroviral therapy: a systematic review and meta-analysis

References

• Abrahams, Z., Levitt, N., Lesosky, M., Maartens, G., & Dave, J. (2016). Changes in body fat distribution on dual-energy X-ray absorptiometry in black South Africans starting first-line antiretroviral therapy. AIDS Patient Care and STDs, 30(10), 455–462. https://doi.org/10.1089/apc.2016.0183
   PubMed Web of Science ®Google Scholar
• Achhra, A. C., Mocroft, A., Reiss, P., Sabin, C., Ryom, L., de Wit, S., Smith, C. J., d’Arminio Monforte, A., Phillips, A., Weber, R., Lundgren, J., & Law, M. G. (2016). Short-term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: The D:A:D study. HIV Medicine, 17(4), 255–268. https://doi.org/10.1111/hiv.12294
   PubMed Web of Science ®Google Scholar
• Akinboro, A. O., Onayemi, O., Ayodele, O. E., Mejiuni, A. D., & Atiba, A. S. (2013). The impacts of first line highly active antiretroviral therapy on serum selenium. CD, 4, count, and body mass index: A cross sectional and short prospective study. Pan African Medical Journal, 15, 97. doi:10.11604/pamj.2013.15.97.2524.
   PubMedGoogle Scholar
• Amorosa, V., Synnestvedt, M., Gross, R., Friedman, H., MacGregor, R. R., Gudonis, D., Frank, I., & Tebas, P. (2005). A tale of 2 epidemics: The intersection between obesity and HIV infection in Philadelphia. Journal of Acquired Immune Deficiency Syndromes, 39(5), 557–561. doi:10.1097/01.qai.0000171638.9b.
   PubMed Web of Science ®Google Scholar
• Armah, K. A., Chang, C. C., Baker, J. V., Ramachandran, V. S., Budoff, M. J., Crane, H. M., Gibert, C. L., Goetz, M. B., Leaf, D. A., McGinnis, K. A., Oursler, K. K., Rimland, D., Rodriguez-Barradas, M. C., Sico, J. J., Warner, A. L., Hsue, P. Y., Kuller, L. H., Justice, A. C., & Freiberg, M. S. (2013). Prehypertension, hypertension, and the risk of acute myocardial infarction in HIV-infected and -uninfected veterans. Clinical Infectious Diseases, 58(1), 121–129. https://doi.org/10.1093/cid/cit652
   PubMed Web of Science ®Google Scholar
• Bala, B., Majumdar, B. B., Pal, J., Datta, S., Talukdar, A., & Das, S. (2016). Study of metabolic complications after 1 year of antiretroviral therapy in HIV-infected patients in a tertiary care center in North Bengal. Annals of Tropical Medicine and Public Health, 9(2), 97–101. https://doi.org/10.4103/1755-6783.177376
   Web of Science ®Google Scholar
• Bezabhe, W. M., Bereznicki, L. R., Chalmers, L., Gee, P., Kassie, D. M., Bimirew, M. A., & Peterson, G. M. (2015). Adverse drug reactions and clinical outcomes in patients initiated on antiretroviral therapy: A prospective cohort study from Ethiopia. Drug Safety, 38(7), 629–639. https://doi.org/10.1007/s40264-015-0295-7
   PubMed Web of Science ®Google Scholar
• Bonnet, E., Ruidavets, J. B., Genoux, A., Mabile, L., Busato, F., Obadia, M., Prévoteau, F., Marchou, B., Massip, P., Marion-Latard, F., Delpierre, C., Bernard, J., & Perret, B. (2013). Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: The prospective Lipotrip study. BMC Infectious Diseases, 13(1), 293. https://doi.org/10.1186/1471-2334-13-293
   PubMedGoogle Scholar
• Crum-Cianflone, N., Tejidor, R., Medina, S., Barahona, I., & Ganesan, A. (2008). Obesity among patients with HIV: The latest epidemic. AIDS Patient Care and STDs, 22(12), 925–930. https://doi.org/10.1089/apc.2008.0082
   PubMed Web of Science ®Google Scholar
• Denue, B. A., Ikunaiye, P. N. Y., & Denue, C. B. A. (2013). Body mass index changes during highly active antiretroviral therapy in Nigeria. Eastern Mediterranean Health Journal, 19(3), S89–S97.
   Google Scholar
• Dirajlal-Fargo, S., Moser, C., Brown, T. T., Kelesidis, T., Dube, M. P., Stein, J. H., Currier, J., & McComsey, G. A. (2016). Changes in insulin resistance after initiation of raltegravir or protease inhibitors with tenofovir-emtricitabine: AIDS Clinical Trials Group A5260s. Open Forum Infectious Diseases, 3(3), ofw174. https://doi.org/10.1093/ofid/ofw174
   PubMed Web of Science ®Google Scholar
• Effective Public Health Practice Project (EPHPP). (2010). Quality assessment tool for quantitative studies. http://www.ephpp.ca/PDF/QualityAssessment Tool_2010_2.pdf
   Google Scholar
• Erlandson, K. M., Taejaroenkul, S., Smeaton, L., Gupta, A., Singini, I. L., Lama, J. R., Mngqibisa, R., Firnhaber, C., Cardoso, S. W., Kanyama, C., Machado da Silva, A. L., Hakim, J. G., Kumarasamy, N., Campbell, T. B., & Hughes, M. D. (2015). A randomized comparison of anthropomorphic changes with preferred and alternative efavirenz-based antiretroviral regimens in diverse multinational settings. Open Forum Infectious Diseases, 2(3), ofv095. https://doi.org/10.1093/ofid/ofv095
   PubMed Web of Science ®Google Scholar
• Esposito, F. M., Coutsoudis, A., Visser, J., & Kindra, G. (2008). Changes in body composition and other anthropometric measures of female subjects on highly active antiretroviral therapy (HAART): A pilot study in Kwazulu-Natal, South Africa. Southern African Journal of Medicine. Spring, 2008.
   Google Scholar
• Evans, D., McNamara, L., Maskew, M., Selibas, K., van Amsterdam, D., Baines, N., Webster, T., & Sanne, I. (2013). Impact of nutritional supplementation on immune response, body mass index and bioelectrical impedance in HIV-positive patients starting antiretroviral therapy. Nutrition Journal, 12(1), 111. https://doi.org/10.1186/1475-2891-12-111
   PubMed Web of Science ®Google Scholar
• George, J. A., Venter, W. D., Van Deventer, H. E., & Crowther, N. J. (2009). A longitudinal study of the changes in body fat and metabolic parameters in a South African population of HIV-positive patients receiving an antiretroviral therapeutic regimen containing stavudine. AIDS Research and Human Retroviruses, 25(8), 771–781. https://doi.org/10.1089/aid.2008.0308
   PubMed Web of Science ®Google Scholar
• Gil, L., Tarinas, A., Hernández, D., Riverón, B. V., Pérez, D., Tápanes, R., Capo, V., & Pérez, J. (2010). Altered oxidative stress indexes related to disease progression marker in human immunodeficiency virus infected patients with antiretroviral therapy. Biomedicine & Aging Pathology, 1(1), 8–15. https://doi.org/10.1016/j.biomag.2010.09.001
   Google Scholar
• Grant, P. M., Kitch, D., McComsey, G. A., Collier, A. C., Bartali, B., Koletar, S. L., Erlandson, K. M., Lake, J. E., Yin, M. T., Melbourne, K., Ha, B., & Brown, T. T. (2016). Long-term body composition changes in antiretroviral-treated HIV-infected individuals. Aids (London, England), 30(18), 2805–2813. https://doi.org/10.1097/QAD.0000000000001248
   PubMed Web of Science ®Google Scholar
• Guehi, C., Badjé, A., Gabillard, D., Ouattara, E., Koulé, S. O., Moh, R., Ekouevi, D., Ahibo, H., N’Takpé, J. B., Menan, G. K., Deschamps, N., Lecarrou, J., Eholié, S., Anglaret, X., & Danel, C. (2016). High prevalence of being overweight and obese HIV-infected persons, before and after 24 months on early ART in the ANRS 12136 Temprano Trial. AIDS Research and Therapy, 13(1), 12. https://doi.org/10.1186/s12981-016-0094-y
   PubMedGoogle Scholar
• Gupta, V., Biswas, A., & Sharma, S. K. (2011). Metabolic and body composition changes after six months of highly active antiretroviral therapy in northern Indian patients. International Journal of STD & AIDS, 22(1), 46–49. https://doi.org/10.1258/ijsa.2010.010193
   PubMed Web of Science ®Google Scholar
• Hasse, B., Iff, M., Ledergerber, B., Calmy, A., Schmid, P., Hauser, C., Bernasconi, E., Böni, J., Bucher, H. C., Burton-Jeangros, C., Calmy, A., Cavassini, M., Egger, M., Elzi, L., Fehr, J., Fellay, J., Furrer, H., Fux, C. A., Gorgievski, M., … Yerly, S. (2014). Obesity trends and body mass index changes after starting antiretroviral treatment: The Swiss HIV Cohort study. Open Forum Infectious Diseases, 1(2), ofu040. https://doi.org/10.1093/ofid/ofu040
   PubMedGoogle Scholar
• Herrin, M., Tate, J. P., Akgün, K. M., Butt, A. A., Crothers, K., Freiberg, M. S., Gibert, C. L., Leaf, D. A., Rimland, D., Rodriguez-Barradas, M. C., Ruser, C. B., Herold, K. C., & Justice, A. C. (2016). Weight gain and incident diabetes among HIV-infected Veterans initiating antiretroviral therapy compared with uninfected individuals. JAIDS Journal of Acquired Immune Deficiency Syndromes, 73(2), 228–236. https://doi.org/10.1097/QAI.0000000000001071
   PubMed Web of Science ®Google Scholar
• Higgins, J. P. T., & Green, S. (2011). Cochrane handbook for systematic reviews of interventions, Version 5.1.0. http://handbook-5-1.cochrane.org/
   Google Scholar
• Huisin 't Veld, D., Balestre, E., Buyze, J., Menten, J., Jaquet, A., Cooper, D. A., Dabis, F., Yiannoutsos, C. T., Diero, L., Mutevedzi, P., Fox, M. P., Messou, E., Hoffmann, C. J., Prozesky, H. W., Egger, M., Hemingway-Foday, J. J., & Colebunders, R. (2015). Determinants of weight evolution among HIV-positive patients initiating antiretroviral treatment in low-resource settings. JAIDS Journal of Acquired Immune Deficiency Syndromes, 70(2), 146–154. https://doi.org/10.1097/QAI.0000000000000691
   PubMed Web of Science ®Google Scholar
• Hurley, E., Coutsoudis, A., Giddy, J., Knight, S. E., Loots, E., & Esterhuizen, T. M. (2011). Weight evolution and perceptions of adults living with HIV following initiation of antiretroviral therapy in a South African urban setting. South African Medical Journal, 101(9), 645–650.
   PubMed Web of Science ®Google Scholar
• Ioannidis, J. P., Patsopoulos, N. A., & Rothstein, H. R. (2008). Reasons or excuses for avoiding meta-analysis in forest plots. BMJ, 336(7658), 1413–1415. https://doi.org/10.1136/bmj.a117
   PubMed Web of Science ®Google Scholar
• Joint United Nations Programme on HIV/AIDS [UNAIDS]. (2018). Global HIV & AIDS statistics — 2018 fact sheet. http://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf
   Google Scholar
• Jones, C. Y., Hogan, J. W., Snyder, B., Klein, R. S., Rompalo, A., Schuman, P., & Carpenter, C. C. (2003). Overweight and human immunodeficiency virus (HIV) progression in women: Associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clinical Infectious Diseases, 37(2), S69–S80. https://doi.org/10.1086/375889
   PubMedGoogle Scholar
• Kalofonos, I. A. (2010). “All I Eat Is ARVs”: The paradox of AIDS treatment interventions in Central Mozambique. Medical Anthropology Quarterly, 24(3), 363–380. https://doi.org/10.1111/j.1548-1387.2010.01109.x
   PubMed Web of Science ®Google Scholar
• Koethe, J. R., Jenkins, C. A., Lau, B., Shepherd, B. E., Justice, A. C., Tate, J. P., Buchacz, K., Napravnik, S., Mayor, A. M., Horberg, M. A., Blashill, A. J., Willig, A., Wester, C. W., Silverberg, M. J., Gill, J., Thorne, J. E., Klein, M., Eron, J. J., Kitahata, M. M., … Moore, R. D. (2015). Rising obesity prevalence and weight gain among adults starting antiretroviral therapy in the United States and Canada. AIDS Research and Human Retroviruses, 32(1), 50–58. https://doi.org/10.1089/aid.2015.0147
   PubMed Web of Science ®Google Scholar
• Kumar, S., & Samaras, K. (2018). The impact of weight gain during HIV treatment on risk of pre-diabetes, diabetes mellitus, cardiovascular disease, and mortality. Frontiers in Endocrinology, 9, 705. https://doi.org/10.3389/fendo.2018.00705
   PubMed Web of Science ®Google Scholar
• Lakey, W., Yang, L. Y., Yancy, W., Chow, S. C., & Hicks, C. (2013). Short communication: From wasting to obesity: Initial antiretroviral therapy and weight gain in HIV-infected persons. AIDS Research and Human Retroviruses, 29(3), 435–440. https://doi.org/10.1089/aid.2012.0234
   PubMed Web of Science ®Google Scholar
• Maia Leite, L. H., & De Mattos Marinho Sampaio, A. B. (2010). Progression to overweight, obesity and associated factors after antiretroviral therapy initiation among Brazilian persons with HIV/AIDS. Nutrición Hospitalaria, 25(4), 635–640.
   PubMed Web of Science ®Google Scholar
• Messou, E., Gabillard, D., Moh, R., Inwoley, A., Sorho, S., Eholié, S., Rouet, F., Seyler, C., Danel, C., & Anglaret, X. (2008). Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in West African adults. Bulletin of the World Health Organization, 86(6), 435–442. doi:10.2471/BLT.07.042911.
   PubMed Web of Science ®Google Scholar
• Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., Altman, D., Antes, G., … Tugwell, P. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Medicine, 6(7), 264–269. https://doi.org/10.1371/journal.pmed.1000097
   Web of Science ®Google Scholar
• Moyle, G. J., Hardy, H., Farajallah, A., DeGrosky, M., & McGrath, D. (2014). Comparison of body composition changes between atazanavir/ritonavir and lopinavir/ritonavir each in combination with tenofovir/emtricitabine in antiretroviral-naive patients with HIV-1 infection. Clinical Drug Investigation, 34(4), 287–296. https://doi.org/10.1007/s40261-014-0175-4
   PubMed Web of Science ®Google Scholar
• Mutimura, E., Hoover, D. R., Shi, Q., Dusingize, J. C., Sinayobye, J. D., Cohen, M., & Anastos, K. (2015). Insulin resistance change and antiretroviral therapy exposure in HIV-infected and uninfected Rwandan women: A longitudinal analysis. PLoS ONE, 10(4), e0123936. https://doi.org/10.1371/journal.pone.0123936
   PubMed Web of Science ®Google Scholar
• Ncube, R. T., Hwalima, Z., Tshimanga, M., Chirenda, J., Mabaera, B., & Apollo, T. (2008). Treatment outcomes of patients on antiretrovirals after six months of treatment, Khami clinic, Bulawayo, Zimbabwe. Central African Journal of Medicine, 54(1–4), 8–15.
   PubMedGoogle Scholar
• Nduka, C. U., Uthman, O. A., Kimani, P. K., & Stranges, S. (2016). Body fat changes in people living with HIV on antiretroviral therapy. AIDS Reviews, 18(4), 198–211.
   PubMed Web of Science ®Google Scholar
• Saghayam, S., Kumarasamy, N., Cecelia, A. J., Solomon, S., Mayer, K., & Wanke, C. (2007). Weight and body shape changes in a treatment-naive population after 6 months of nevirapine-based generic highly active antiretroviral therapy in South India. Clinical Infectious Diseases, 44(2), 295–300. https://doi.org/10.1086/510491
   PubMed Web of Science ®Google Scholar
• Sarna, A., Luchters, S., Geibel, S., Chersich, M. F., Munyao, P., Kaai, S., Mandaliya, K. N., Shikely, K. S., Temmerman, M., & Rutenberg, N. (2008). Short- and long-term efficacy of modified directly observed antiretroviral treatment in Mombasa, Kenya: A randomized trial. JAIDS Journal of Acquired Immune Deficiency Syndromes, 48(5), 611–619. https://doi.org/10.1097/QAI.0b013e3181806bf1
   PubMed Web of Science ®Google Scholar
• Tang, A. M., Sheehan, H. B., Jordan, M. R., Duong, D. V., Terrin, N., Dong, K., Trinh Thi Minh Lien, Nguyen Vu Trung, Christine A. Wanke, Hien, N. D. (2011). Predictors of weight change in male HIV-positive injection drug users initiating antiretroviral therapy in Hanoi, Vietnam. AIDS Research and Treatment, 890308.
   PubMedGoogle Scholar
• Taramasso, L., Ricci, E., Menzaghi, B., Orofino, G., Passerini, S., Madeddu, G., Martinelli, C. V., De Socio, G. V., Squillace, N., Rusconi, S., Bonfanti, P., Di Biagio, A., Quirino, T., Bonfanti, P., Ricci, E., Bellacosa, C., Maggi, P., Calza, L., Abeli, C., … Caramell, P. (2017). Weight gain: A possible side effect of all antiretrovirals. Open Forum Infectious Diseases, 4(4), ofx239. https://doi.org/10.1093/ofid/ofx239
   PubMed Web of Science ®Google Scholar
• Tate, T., Willig, A. L., Willig, J. H., Raper, J. L., Moneyham, L., Kempf, M.-C., Saag, M. S., & Mugavero, M. J. (2012). HIV infection and obesity: Where did all the wasting go? Antiviral Therapy, 17(7), 1281–1289. https://doi.org/10.3851/IMP2348
   PubMed Web of Science ®Google Scholar
• Tiéno, H., Guira, O., Sagna, Y., Diendéré, E. A., Diallo, I., Bognounou, R., Zoungrana, L., Zida, S., Nikiéma, P., & Drabo, Y. J. (2015). Characteristics and follow-up of newly managed HIV-infected patients in the national referral center in Ouagadougou, Burkina Faso. Journal of the International Association of Providers of AIDS Care (JIAPAC), 14(1), 40–45. https://doi.org/10.1177/2325957412470722
   PubMedGoogle Scholar
• van Oosterhout, J. J., Ndekha, M., Moore, E., Kumwenda, J. J., Zijlstra, E. E., & Manary, M. (2010). The benefit of supplementary feeding for wasted Malawian adults initiating ART. AIDS Care, 22(6), 737–742. https://doi.org/10.1080/09540120903373581
   PubMed Web of Science ®Google Scholar
• The World Bank Group. (2019). World Bank country and lending groups: Country classification. https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
   Google Scholar
• Yuh, B., Tate, J., Butt, A. A., Crothers, K., Freiberg, M., Leaf, D., Logeais, M., Rimland, D., Rodriguez-Barradas, M. C., Ruser, C., & Justice, A. C. (2015). Weight change after antiretroviral therapy and mortality. Clinical Infectious Diseases, 60(12), 1852–1859. https://doi.org/10.1093/cid/civ192
   PubMed Web of Science ®Google Scholar